PT  - JOURNAL ARTICLE
AU  - Giuseppe Derosa
TI  - Nateglinide does not reduce the incidence of diabetes or cardiovascular outcomes in people with impaired glucose tolerance and cardiovascular disease or risk factors
AID  - 10.1136/ebm1100
DP  - 2011 Feb 01
TA  - Evidence Based Medicine
PG  - 7--8
VI  - 16
IP  - 1
4099  - http://ebm.bmj.com/content/16/1/7.short
4100  - http://ebm.bmj.com/content/16/1/7.full
SO  - Evid Based Med2011 Feb 01; 16